Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangmin Tong

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Cell Death & Disease|July 15, 2021
DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolismJing Du, Xu Wang, Yanchun Li, et al.
Journal of Clinical Medicine|September 9, 2022
Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter AnalysisSiyu Liu, Liyang Sun, Lanqing Yao, et al.
Frontiers in Oncology|March 6, 2023
A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancerQiangan Jing, Hongfeng Yao, Huanjuan Li, et al.
Cancer Cell International|December 30, 2021
FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasisWanye Hu, Chaoting Zhou, Qiangan Jing, et al.
Theranostics|August 27, 2025
Synergistic tumor microenvironment modulation enabled by a nanozyme-boosted biomimetic macrophage-derived nanovesicle for highly efficient antitumor therapyYue Su, Haibin Wu, Ke Duan, et al.
Free Radical Biology & Medicine|June 12, 2024
GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromesHuanjuan Li, Yanchun Li, Yanhua Yu, et al.
European Journal of Haematology|April 22, 2026
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaLin Song, Xudong Wei, Zhimin Zhai, et al.
Redox Biology|September 5, 2021
Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosisXueying Ren, Yanchun Li, Yi Zhou, et al.
Redox Biology|December 27, 2023
Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosisPing Zhang, Chaoting Zhou, Xueying Ren, et al.
Redox Biology|March 15, 2020
Identification of Frataxin as a regulator of ferroptosisJing Du, Yi Zhou, Yanchun Li, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Cell Death & Disease|July 15, 2021
DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolismJing Du, Xu Wang, Yanchun Li, et al.
Journal of Clinical Medicine|September 9, 2022
Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter AnalysisSiyu Liu, Liyang Sun, Lanqing Yao, et al.
Frontiers in Oncology|March 6, 2023
A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancerQiangan Jing, Hongfeng Yao, Huanjuan Li, et al.
Cancer Cell International|December 30, 2021
FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasisWanye Hu, Chaoting Zhou, Qiangan Jing, et al.
Theranostics|August 27, 2025
Synergistic tumor microenvironment modulation enabled by a nanozyme-boosted biomimetic macrophage-derived nanovesicle for highly efficient antitumor therapyYue Su, Haibin Wu, Ke Duan, et al.
Free Radical Biology & Medicine|June 12, 2024
GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromesHuanjuan Li, Yanchun Li, Yanhua Yu, et al.
European Journal of Haematology|April 22, 2026
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaLin Song, Xudong Wei, Zhimin Zhai, et al.
Redox Biology|September 5, 2021
Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosisXueying Ren, Yanchun Li, Yi Zhou, et al.
Redox Biology|December 27, 2023
Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosisPing Zhang, Chaoting Zhou, Xueying Ren, et al.
Redox Biology|March 15, 2020
Identification of Frataxin as a regulator of ferroptosisJing Du, Yi Zhou, Yanchun Li, et al.
Pageof 13